Cerevel Therapeutics Holdings, - stock earnings
CERE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -132.7 million USD | ? USD |
| 2023Q3 | -96.4 million USD | ? USD |
| 2023Q2 | -99.5 million USD | ? USD |
| 2023Q1 | -104.3 million USD | ? USD |
| 2022Q4 | -92.8 million USD | ? USD |
| 2022Q3 | -104.8 million USD | ? USD |
| 2022Q2 | -87.9 million USD | ? USD |
| 2022Q1 | -64.1 million USD | ? USD |
| 2021Q4 | -59.1 million USD | ? USD |
| 2021Q3 | -62.1 million USD | ? USD |
| 2021Q2 | -53.2 million USD | ? USD |
| 2021Q1 | -51.0 million USD | ? USD |
| 2020Q4 | -33.2 million USD | ? USD |
| 2020Q3 | -39.0 million USD | ? USD |
| 2020Q2 | -26.7 million USD | ? USD |
| 2020Q1 | -53.2 million USD | ? USD |
| 2016Q2 | -1.5 million USD | 1.4 million USD |
| 2016Q1 | -1.1 million USD | 351000 USD |
| 2015Q4 | -3.4 million USD | 942000 USD |
| 2015Q3 | -8.2 million USD | 852000 USD |
| 2015Q2 | -5.9 million USD | 1.1 million USD |
| 2015Q1 | -8.1 million USD | 343000 USD |
| 2014Q4 | -6.0 million USD | 400000 USD |
| 2014Q3 | -6.2 million USD | 340000 USD |
| 2014Q2 | -7.7 million USD | 806000 USD |
| 2014Q1 | -7.2 million USD | 495000 USD |
| 2013Q4 | -8.2 million USD | 763000 USD |
| 2013Q3 | 25.2 million USD | 897000 USD |
| 2013Q2 | -9.3 million USD | 1.4 million USD |
| 2013Q1 | -9.0 million USD | 1.0 million USD |
| 2012Q4 | -6.9 million USD | 2.0 million USD |
| 2012Q3 | -6.6 million USD | 1.2 million USD |
| 2012Q2 | -8.4 million USD | 1.1 million USD |
| 2012Q1 | -8.4 million USD | 1.1 million USD |
| 2011Q4 | 1.7 million USD | -3.7 million USD |
CERE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -432.8 million USD | ? USD |
| 2022 | -351.5 million USD | ? USD |
| 2021 | -222.4 million USD | ? USD |
| 2020 | -152.1 million USD | ? USD |
| 2019 | -128.4 million USD | ? USD |
| 2018 | -463.6 million USD | ? USD |
| 2015 | -28.2 million USD | 2.7 million USD |
| 2014 | -29.3 million USD | 2.4 million USD |
| 2013 | -32.5 million USD | 5.2 million USD |
| 2012 | -29.4 million USD | 5.4 million USD |
CERE
Price: $42.55
52 week price:
Earnings Per Share: -2.67 USD
P/E Ratio: -17.17
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 300700
Market Capitalization: 7.6 billion